- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Adenovirus
- Respiratory syncytial virus infection
- Influenza
- COVID-19
- Adenovirus infection
- Diagnostics
- Point of care tests
Population: General population
Individuals who do not belong to a defined subgroup with specific characteristics, representing the broader population
- General population
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Emergency department
- Respiratory syncytial virus
- Adenovirus
- Rhinovirus
- Human metapneumovirus
- Parainfluenza Virus
- Group A Streptococcus
- Influenza A virus
- Influenza B virus
- Respiratory syncytial virus infection
- Influenza
- Adenovirus infection
- Rhinovirus infection
- Parainfluenza
- Metapneumovirus infection
- Group A Streptococcus infection
- Diagnostics
- Point of care tests
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Adenovirus
- Rhinovirus
- Human metapneumovirus
- Parainfluenza Virus
- Enterovirus
- Bordetella pertussis
- Seasonal coronavirus
- Bordetella parapertussis
- Chlamydia pneumoniae
- Mycoplasma pneumoniae
- Respiratory syncytial virus infection
- Influenza
- COVID-19
- Adenovirus infection
- Rhinovirus infection
- Enterovirus infection
- Human metapneumovirus infection
- Parainfluenza
- Bordetella parapertussis infection
- Bordetella pertussis infection
- Chlamydia pneumoniae infection
- Mycoplasma pneumoniae infection
- Diagnostics
- Point of care tests
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Primary care
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- General population
- Infants (<1 year)
- Children (1-11 years)
- Primary care
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- General population
- Infants (<1 year)
- Children (1-11 years)
- Hospital
- Emergency department
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Respiratory syncytial virus infection
- Influenza
- COVID-19
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Primary care
- Pharmacological intervention
- Telehealth
- General population
- Infants (<1 year)
- Children (1-11 years)
- Community
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Adenovirus
- Rhinovirus
- Human metapneumovirus
- Parainfluenza Virus
- Enterovirus
- Seasonal coronavirus
- Bocavirus
- Respiratory syncytial virus infection
- Influenza
- COVID-19
- Adenovirus infection
- Rhinovirus infection
- Enterovirus infection
- Human metapneumovirus infection
- Parainfluenza
- Bocavirus infection
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Community
- SARS-CoV-2
- COVID-19
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- Hantavirus
- Puumala virus
- Hantavirus infection
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Hantavirus
- Puumala virus
- Hantaan virus
- Hantavirus infection
- Serum sample